By clicking “CONTINUE” below, you will be taken to a website that may contain links or references to other websites to which our Privacy Policy may not apply. We encourage you to read the Privacy Policy of every website you visit.
You are solely responsible for your interactions with such websites.
The information contained in this section of the site is intended for US healthcare professionals only.
Click the appropriate link below.
Please see full Prescribing Information, including BOXED WARNING for OPSUMIT®.
Please see full Prescribing Information, including BOXED WARNING for TRACLEER®.
Please see full Prescribing Information for VENTAVIS®.
Please see full Prescribing Information for UPTRAVI®.
Clicking CONTINUE below will take you to the selected site, the content for which Janssen is not responsible and to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every online service you visit.
CONTINUE
RETURN TO PREVIOUS PAGEFor medical information on VELETRI® (epoprostenol) for Injection, please contact our Medical Information Department.
Actelion Pharmaceuticals US, Inc.
5000 Shoreline Court, Suite
200 South San Francisco, CA 94080
To report suspected adverse reactions, contact Janssen at 1-800-JANSSEN (1-800-526-7736), or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
1-800-JANSSEN (1-800-526-7736)
1-415-268-9515
Patients should always talk with their healthcare team first if there are any questions about their individual treatment.
